Terms: = Gastric cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Prognosis
44 results:
1. Analyzing the associations between tertiary lymphoid structures and postoperative prognosis, along with immunotherapy response in gastric cancer: findings from pooled cohort studies.
Peng H; Wu X; Zhang C; Liang Y; Cheng S; Zhang H; Shen L; Chen Y
J Cancer Res Clin Oncol; 2024 Mar; 150(3):153. PubMed ID: 38519621
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive analysis of tertiary lymphoid structures-related genes for prognostic prediction, molecular subtypes and immune infiltration in gastric cancer.
Zhou Q; Lan L; Wang W; Xu X; Wang W
Aging (Albany NY); 2023 Nov; 15(22):13368-13383. PubMed ID: 38015717
[TBL] [Abstract] [Full Text] [Related]
3. Development and Validation of a Machine Learning Model for Detection and Classification of Tertiary Lymphoid Structures in Gastrointestinal cancers.
Li Z; Jiang Y; Li B; Han Z; Shen J; Xia Y; Li R
JAMA Netw Open; 2023 Jan; 6(1):e2252553. PubMed ID: 36692877
[TBL] [Abstract] [Full Text] [Related]
4. The developmental regulator HAND1 inhibits gastric carcinogenesis through enhancing ER stress apoptosis
Kuang Y; He Z; Li L; Wang C; Cheng X; Shi Q; Fu G; Ying J; Tao Q; Hu X
Int J Biol Sci; 2023; 19(1):120-136. PubMed ID: 36594085
[TBL] [Abstract] [Full Text] [Related]
5. Impact of mature tertiary lymphoid structures on prognosis and therapeutic response of Epstein-Barr virus-associated gastric cancer patients.
Yin YX; Ling YH; Wei XL; He CY; Wang BZ; Hu CF; Lin WP; Nie RC; Chen JW; Lin JL; Zhou J; Xie JJ; Yun JP; Xie D; Xue LY; Cai MY
Front Immunol; 2022; 13():973085. PubMed ID: 36591236
[TBL] [Abstract] [Full Text] [Related]
6. Tertiary lymphoid structures and gastric cancer prognosis.
Kemi N; Ylitalo O; Väyrynen JP; Helminen O; Junttila A; Mrena J; Böhm J; Kauppila JH
APMIS; 2023 Jan; 131(1):19-25. PubMed ID: 36205614
[TBL] [Abstract] [Full Text] [Related]
7. Asiaticoside Suppresses gastric cancer Progression and Induces Endoplasmic Reticulum Stress through the miR-635/HMGA1 Axis.
Zhang C; Ji X; Chen Z; Yao Z
J Immunol Res; 2022; 2022():1917585. PubMed ID: 35692504
[TBL] [Abstract] [Full Text] [Related]
8. The transformation of isolated gastric myeloid sarcoma into acute myeloid leukemia presenting with a complex karyotype and tls-ERG gene fusion: A case report.
Gao L; Xu Y; Tian Z; Xia J; Yuan Z; Chen D; Ren M
Medicine (Baltimore); 2022 May; 101(21):e29475. PubMed ID: 35623083
[TBL] [Abstract] [Full Text] [Related]
9. Peritumoral TIGIT
Liu H; Wu J; Xu X; Wang H; Zhang C; Yin S; He Y
Int Immunopharmacol; 2022 Jul; 108():108735. PubMed ID: 35405596
[TBL] [Abstract] [Full Text] [Related]
10. Clinical efficacy of nivolumab is associated with tertiary lymphoid structures in surgically resected primary tumors of recurrent gastric cancer.
Mori T; Tanaka H; Deguchi S; Yamakoshi Y; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Muguruma K; Ohira M
PLoS One; 2022; 17(1):e0262455. PubMed ID: 34995329
[TBL] [Abstract] [Full Text] [Related]
11. Disseminated Carcinomatosis of Bone Marrow as the Initial Presentation of Intrahepatic Cholangiocarcinoma without Jaundice: An Autopsy Case Report.
Okumura T; Mitsui K; Daikuhara S; Tatai T; Itagaki H; Miyabayashi H; Gibo Y
Intern Med; 2022 Mar; 61(5):657-662. PubMed ID: 34483207
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic Value of Tumor-Infiltrating Lymphocytes and Tertiary Lymphoid Structures in Epstein-Barr Virus-Associated and -Negative gastric Carcinoma.
Cheng N; Li P; Cheng H; Zhao X; Dong M; Zhang Y; Zhao P; Chen J; Shao C
Front Immunol; 2021; 12():692859. PubMed ID: 34276684
[TBL] [Abstract] [Full Text] [Related]
13. The Role of Tumor-related LncRNA PART1 in cancer.
Chen J; Meng E; Lin Y; Shen Y; Hu C; Zhou G; Yuan C
Curr Pharm Des; 2021; 27(40):4152-4159. PubMed ID: 34225608
[TBL] [Abstract] [Full Text] [Related]
14. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer.
Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485
[TBL] [Abstract] [Full Text] [Related]
15. Absolute Monocyte and Platelet Counts May Provide Additional Prognostic Information in Primary gastric Diffuse Large B-cell Lymphoma Patients Treated with Rituximab and chop.
Spassov B; Vassileva D; Nikolov S; Ganeva P; Balatzenko G; Guenova M
Folia Med (Plovdiv); 2020 Dec; 62(4):785-801. PubMed ID: 33415923
[TBL] [Abstract] [Full Text] [Related]
16. Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure.
Lin Z; Huang L; Li S; Gu J; Cui X; Zhou Y
Sci Rep; 2020 Dec; 10(1):21530. PubMed ID: 33299035
[TBL] [Abstract] [Full Text] [Related]
17. Will Baseline Total Lesion Glycolysis Play a Role in Improving the Prognostic Value of the NCCN-IPI in Primary gastric Diffuse Large B-Cell Lymphoma Patients Treated With the R-chop Regimen?
Jiang C; Ding C; Xu J; Teng Y; Chen J; Wang Z; Zhou Z
Clin Nucl Med; 2021 Jan; 46(1):1-7. PubMed ID: 33181743
[TBL] [Abstract] [Full Text] [Related]
18. Pattern of failure and optimal treatment strategy for primary gastric diffuse large B-cell lymphoma treated with R-chop chemotherapy.
Kang HJ; Lee HH; Jung SE; Park KS; O JH; Jeon YW; Choi BO; Cho SG
PLoS One; 2020; 15(9):e0238807. PubMed ID: 32960887
[TBL] [Abstract] [Full Text] [Related]
19. Incidence rates and clinical characteristics of primary gastrointestinal non-Hodgkin lymphoma: a population study.
Dizengof V; Levi I; Etzion O; Fich A; Blum A; Chertok IRA; Ben-Yakov G; Rouvio O; Greenbaum U
Eur J Gastroenterol Hepatol; 2020 May; 32(5):569-574. PubMed ID: 31895909
[TBL] [Abstract] [Full Text] [Related]
20. Primary gastric diffuse large B-cell lymphoma: The role of dose-dense chemotherapy.
Avilés A; Nambo MJ; Neri N
J Oncol Pharm Pract; 2019 Oct; 25(7):1682-1686. PubMed ID: 30370804
[TBL] [Abstract] [Full Text] [Related]
[Next]
